| Trial ID: | L0719 |
| Source ID: | IRCT20120415009472N20
|
| Associated Drug: |
Rosemary
|
| Title: |
Effects of Rosemary (Rosmarinus officinalis) Leaves Powder And Weight Reducing Diet on Lipid Profile, Glycemic Status And Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group A (n = 60): Low-calorie diet and physical activity design based on the Adult Overweight and Obesity Control Guide (published by the US National Heart, Lung, and Blood Institute). The energy required for each patient is c
|
| Outcome Measures: |
ALT. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Colorimetric method.;AST. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Colorimetric method.;ALP. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Colorimetric method.;GGT. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Colorimetric method.;TG. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzyme colorimetric method.;TC. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzyme colorimetric method.;HDL-C. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzyme colorimetric method.;FBS. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic calorie meter method.;Insulin. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: ELISA.;LDL-C. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: calculation.;HOMA-Insulin resistance. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: calculation.;HOMA- ??%. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: calculation.;QUICKI. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: calculation.Weight. Timepoint: Before intervention and 8 months after intervention. Method of measurement: Scales.;Height. Timepoint: Before intervention and 8 months after intervention. Method of measurement: Meter.;Waist. Timepoint: Before intervention and 8 months after intervention. Method of measurement: Meter.;BMI. Timepoint: Before intervention and 8 months after intervention. Method of measurement: calculation.
|
| Sponsor/Collaborators: |
Vice-chancellor for research Iran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years65 years
|
| Phases: |
Phase 2
|
| Enrollment: |
120
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: For randomized allocation performing, permuted block randomization will be used by quadrilateral blocks. According to
|
| Start Date: |
12/11/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
17 December 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/37196
|
